Laurion Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-723
Closed -$241K 359
2024
Q3
$241K Buy
+723
New +$275K ﹤0.01% 244
2023
Q3
Sell
-3,914
Closed -$940K 596
2023
Q2
$940K Buy
+3,914
New +$813K 0.01% 372
2020
Q4
Sell
-9,200
Closed -$1.03M 843
2020
Q3
$1.03M Buy
+9,200
New +$1.06M 0.01% 427
2019
Q1
Sell
-66,440
Closed -$3.52M 1120
2018
Q4
$3.52M Sell
66,440
-1,042,116
-94% -$57.2M 0.06% 352
2018
Q3
$66.4M Buy
1,108,556
+428,785
+63% +$23.5M 0.64% 17
2018
Q2
$29.2M Buy
+679,771
New +$27.5M 0.23% 96
2018
Q1
Sell
-12,100
Closed -$439K 1539
2017
Q4
$439K Buy
+12,100
New +$424K ﹤0.01% 1202

Other funds holding MEDP

Laurion Capital Management's MEDP Position: Q4 2024 in Review

Laurion Capital Management sold out of Medpace (MEDP) in Q4 2024, closing a stake of 723 shares — an estimated $241K sold.

Laurion Capital Management first reported a position in MEDP in Q4 2017 and held it in 7 quarters. The position peaked at $66.4M in Q3 2018. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Laurion Capital Management reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Laurion Capital Management sold 723 Medpace shares in Q4 2024, an estimated $241K.
  • Laurion Capital Management first reported a position in Medpace in Q4 2017 and held it in 7 quarters.
  • Laurion Capital Management's Medpace position peaked at $66.4M in Q3 2018.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Laurion Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.